Hemoglobin-Based Oxygen Carriers Promoted the Antitumor Effect of 177 Lu-PSMA-617 by Enhancing DNA Repair Capacity of Immune Cells

Cancer Biotherapy and Radiopharmaceuticals · Published 2026-05-22 · DOI 10.1177/10849785261448523

Authors (11)

Danyue Qu, Chenyi Shao, Xinyuan Ji, Yichi Huang, Chen Tian, Jiaze Li, Hu Zhou, Yilei Shi, Hong Wang, Jiaxin Liu, Yu Zhao

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Qu, D., Shao, C., Ji, X., et al. (2026). Hemoglobin-Based Oxygen Carriers Promoted the Antitumor Effect of 177 Lu-PSMA-617 by Enhancing DNA Repair Capacity of Immune Cells. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1177/10849785261448523

Related articles

• Boronophenylalanine-Mediated Boron Neutron Capture Therapy Confers Selective Killing of Cervical Cancer by Exploiting DNA Repair Deficiency · Cancer Biotherapy and Radiopharmaceuticals · 2026 · Same journal
• Neural Decoding of Ultrasound-Modulated Pain States via Deep Learning: Insights from Functional Magnetic Resonance Imaging Data · Cancer Biotherapy and Radiopharmaceuticals · 2026 · Same journal
• Prognostic Factor Analysis and Nomogram Development in Castration-Resistant Prostate Cancer with Visceral Metastases for Future Radionuclide Therapy Selection · Cancer Biotherapy and Radiopharmaceuticals · 2026 · Same journal
• Mapping the Intersection of Traditional Chinese Medicine and Ultrasound Therapies in Tumor Microenvironment Research (2014–2024): A Knowledge Atlas Study · Cancer Biotherapy and Radiopharmaceuticals · 2026 · Same journal
• CavitoMod-UTMDNet: A Mechanistic Cavitation–Diffusion Framework for Ultrasound-Targeted Microbubble Destruction–Enhanced Liposomal Doxorubicin Delivery in Pancreatic Cancer · Cancer Biotherapy and Radiopharmaceuticals · 2026 · Same journal
• Development of a Freeze-Dried Bevacizumab Kit for 99m Tc Radiolabeling and Preclinical Evaluation In Vitro and in Normal Mice · Cancer Biotherapy and Radiopharmaceuticals · 2026 · Same journal
• Radionuclide Therapy Integrated Multimodal Transsylvian Microneurosurgical Management of Type 5 Insular and Paralimbic Gliomas for Precision Oncology · Cancer Biotherapy and Radiopharmaceuticals · 2026 · Same journal
• Ultrasound-Potentiated Targeting of GLS1 by an Oridonin Derivative (R13) in Multiple Myeloma: Therapeutic Efficacy and Safety Considerations · Cancer Biotherapy and Radiopharmaceuticals · 2026 · Same journal
• Prospective Clinical Assessment of Ultrasound-Assisted Radiopharmaceutical Imaging Under Anesthesia for Oncologic Evaluation · Cancer Biotherapy and Radiopharmaceuticals · 2026 · Same journal
• Expanding the Therapeutic Window in Oncology: Modern Strategies and Future Directions · Cancer Biotherapy and Radiopharmaceuticals · 2026 · Same journal